KALYDECO 150 mg, film-coated tablet 28 tablets
Active ingredients: Ivacaftor
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KALYDECO 150 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)
- Marketing authorisation holder
- VERTEX PHARMACEUTICALS (IRELAND)
- Reimbursement according to BDPM
- 65 %
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Mucoviscidose chez les personnes âgés de 6 ans et plus, porteuses de certaines caractéristiques génétiques précises. ; JOURNAL OFFICIEL ; 04/02/20
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65036318CIP73015948CIP133400930159484Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IVACAFTORcomprimé | 150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.